S
TSHA icon

SignatureFD’s Taysha Gene Therapies TSHA Stock Holding History

SignatureFD’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19K Buy
266
+206
+343% +$958 ﹤0.01% 3170
2025
Q4 		$330 Buy
+60
New +$291 ﹤0.01% 3267
2025
Q2 		– Sell
-553
Closed -$769 – 3432
2025
Q1 		$769 Buy
553
+271
+96% +$453 ﹤0.01% 3100
2024
Q4 		$488 Buy
282
+107
+61% +$222 ﹤0.01% 3143
2024
Q3 		$352 Buy
+175
New +$384 ﹤0.01% 3136
2024
Q1 		– Sell
-50
Closed -$89 – 3260
2023
Q4 		$89 Buy
+50
New +$100 ﹤0.01% 3088
2022
Q2 		– Sell
-165
Closed -$1K – 3348
2022
Q1 		$1K Buy
+165
New +$1.23K ﹤0.01% 3070

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM